| 영문 | whooping cough, pertussis | 한글 | 백일해 |
|---|---|---|---|
| 설명 | 이것은 주로 소아에서 백일해 균에 의해서 발생하는 상기도(위쪽의 기도를 말함. 즉 인두, 후두, 기관을 말함)감염증이다. 특징적인 갑작스런 큰 기침이 증상으로 나타난다. 치료는 항생제의 투여이며, 때로는 폐렴으로 발전하기도 한다. 현재 우리나라에서는 백일해에 대한 예방접종을 디프테리아(diphteria), 파상풍(tetanus)과 같이 실시하고 있다. |
||
| 영문 | adjuvant | 한글 | 항원보강제 |
|---|---|---|---|
| 설명 | 항암제나 항생제, 또는 기타의 약물에서 같이 투여 또는 시행할 때에 그 약물의 약리작용을 강화할 수 있는, 또는 그런 목적으로 약물과 같이 사용하는 물질. |
||
| DPT | Diphtheria-Pertussis-Tetanus; 디프테리아, 백일해, 파상풍 |
|---|---|
| DTP | Diphtheria, Tetanus, Pertussis 디프테리아, 파상풍, 백일해 혼합 백신 |
| DPI | daily permissible intake; days post inoculation; dietary protein intake; diphtheria-pertussis immuni... |
| DPT | Demerol, Phenergan, and Thorazine; dermatopontin; dichotic pitch discrimination test; diphtheria-per... |
| DPTPM | diphtheria-pertussis-tetanus-poliomyelitis-measles [vaccine] |
| AA | Adjuvant Arthritic |
|---|---|
| AA | Adjuvant induced arthritis |
| AIA | Adjuvant induced arthritis |
| CFA | Complete Freund Adjuvant |
| FCA | Freund Complete Adjuvant |
| adjuvant | 1. <pharmacology> A substance that, when added to a medicine, speeds or improves its action which aids another, such as an auxiliary remedy 2. <immunology> A substance added to a vaccine to improve the immune response so that less vaccine is needed to produce a non-specific stimulator (for example, BCG vaccine) of the immune response. Origin: L. Adjuvans = aiding (18 Nov 1997) |
|---|---|
| adjuvant analgesic | <pharmacology> A drug that is not a primary analgesic but that research has shown to have independent or additive analgesic properties. (16 Dec 1997) |
| adjuvant chemotherapy | <oncology, pharmacology> Chemotherapy treatment that is given as an add-on to their primary cancer treatment, as in surgery or radiation therapy. (16 Dec 1997) |
| adjuvant therapy | <oncology, pharmacology> Treatment that is added to increase the effectiveness of a primary treatment. In cancer, adjuvant treatment usually refers to chemotherapy, hormonal therapy or radiation therapy after surgery to increase the likelihood of killing all cancer cells. (14 May 1997) |
| adjuvant vaccine | A vaccine that contains an adjuvant; most often the antigen (immunogen) is included in a water-in-oil emulsion (Freund incomplete type adjuvant), or is adsorbed onto an inorganic gel (alum, aluminum hydroxide or phosphate). (05 Mar 2000) |
| arthritis, adjuvant | An arthritis experimentally induced in animals with freund's adjuvant. (12 Dec 1998) |
| Bordetella pertussis | <bacteria> A small, aerobic, gram-negative bacillus, causative organism of whooping cough. Produces a variety of toxins including a dermonecrotising toxin, an adenyl cyclase, an endotoxin and pertussis toxin, as well as surface components such as fimbrial haemagglutinin. (18 Nov 1997) |
| radiotherapy, adjuvant | Radiotherapy given to augment some other form of treatment such as surgery or chemotherapy. Adjuvant radiotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment. (12 Dec 1998) |
| chemotherapy, adjuvant | Drug therapy given to augment or stimulate some other form of treatment such as surgery or radiation therapy. Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment. (12 Dec 1998) |
| pertussis | <infectious disease> An acute, highly contagious infection of the respiratory tract, most frequently affecting young children, usually caused by Bordetella pertussis, a similar illness has been associated with infection by B. Parapertussis and B. Bronchiseptica. It is characterised by a catarrhal stage, beginning after an incubation period of about two weeks, with slight fever, sneesing, running at the nose and a dry cough. In a week or two the paroxysmal stage begins, with the characteristic paroxysmal cough, consisting of a deep inspiration, followed by a series of quick, short coughs, continuing until the air is expelled from the lungs, the close of the paroxysm is marked by a long drawn, shrill, whooping inspiration, due to spasmodic closure of the glottis. This stage lasts three to four weeks, after which the convalescent stage begins, in which paroxysms grow less frequent and less violent and finally cease. Synonym: whooping cough. Origin: L. Tussis = cough (18 Nov 1997) |
| pertussis immune globulin | A sterile solution of globulin's derived from the plasma of adult human donors who have been immunised with pertussis vaccine; used both prophylactically and therapeutically. Synonym: pertussis immunoglobulin. (05 Mar 2000) |
| pertussis immunoglobulin | A sterile solution of globulin's derived from the plasma of adult human donors who have been immunised with pertussis vaccine; used both prophylactically and therapeutically. Synonym: pertussis immunoglobulin. (05 Mar 2000) |
| pertussis-like syndrome | <syndrome> A syndrome characterised by severe episodes of coughing resembling whooping cough (pertussis). (05 Mar 2000) |
| pertussis syndrome | <infectious disease> An acute, highly contagious infection of the respiratory tract, most frequently affecting young children, usually caused by Bordetella pertussis, a similar illness has been associated with infection by B. Parapertussis and B. Bronchiseptica. It is characterised by a catarrhal stage, beginning after an incubation period of about two weeks, with slight fever, sneesing, running at the nose and a dry cough. In a week or two the paroxysmal stage begins, with the characteristic paroxysmal cough, consisting of a deep inspiration, followed by a series of quick, short coughs, continuing until the air is expelled from the lungs, the close of the paroxysm is marked by a long drawn, shrill, whooping inspiration, due to spasmodic closure of the glottis. This stage lasts three to four weeks, after which the convalescent stage begins, in which paroxysms grow less frequent and less violent and finally cease. Synonym: whooping cough. Origin: L. Tussis = cough (18 Nov 1997) |
| pertussis toxin | <protein> Protein complex (ca 117 kD). An A B toxin, the active subunit is a single polypeptide 28 kD), the binding subunit a pentamer (two heterodimers, 23 + 11.7 kD, 11.7 + 22 kD and a monomer (9.3 kD) that binds the heterodimers). The active subunit ADP ribosylates the _ subunit of the inhibitory GTP-binding protein (Gi). Crucial to the pathogenicity of Bordetella pertussis, the causative agent of whooping cough. (18 Nov 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|